Skip to main content
Veterinary Medicines

ORIKAN

Not authorised
  • NEOMYCIN SULFATE
  • Triamcinolone acetonide
  • Nystatin
  • Thiostrepton

Product identification

Medicine name:
ORIKAN
Active substance:
  • NEOMYCIN SULFATE
  • Triamcinolone acetonide
  • Nystatin
  • Thiostrepton
Target species:
  • Dog
  • Cat
Route of administration:
  • Auricular use

Product details

Active substance and strength:
  • NEOMYCIN SULFATE
    2841.00
    international unit(s)
    /
    1.00
    gram(s)
  • Triamcinolone acetonide
    1.13
    milligram(s)
    /
    1.00
    gram(s)
  • Nystatin
    113636.00
    international unit(s)
    /
    1.00
    gram(s)
  • Thiostrepton
    2841.00
    international unit(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Ear ointment
Withdrawal period by route of administration:
  • Auricular use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QS02CA04
Authorisation status:
  • Surrendered
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratoire Perrigo France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Elanco France S.A.S.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/2025808 5/2012
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 7/04/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."